Clinical Trial Update: A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD) [Phase 2]

View source ↗

Summary

This document reports on a Phase 2 clinical trial of Bitopertin (RO4917838) in combination with SSRIs for obsessive-compulsive disorder. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Bitopertin (bitopertin)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: COMPLETED